| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADA
|
adenosine deaminase
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMH
|
anti-Mullerian hormone
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
API5
|
apoptosis inhibitor 5
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARSA
|
arylsulfatase A
|
|
AS3MT
|
arsenite methyltransferase
|
|
ATF6
|
activating transcription factor 6
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATG7
|
autophagy related 7
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP6V0A2
|
ATPase, H+ transporting, lysosomal V0 subunit a2
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AUH
|
AU RNA binding protein/enoyl-CoA hydratase
|
|
AURKA
|
aurora kinase A
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B2M
|
beta-2-microglobulin
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BSG
|
basigin (Ok blood group)
|
|
C3
|
complement component 3
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALCRL
|
calcitonin receptor-like
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND3
|
cyclin D3
|
|
CD14
|
CD14 molecule
|
|
CD209
|
CD209 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD48
|
CD48 molecule
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD86
|
CD86 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CENPA
|
centromere protein A
|
|
CES1
|
carboxylesterase 1
|
|
CES2
|
carboxylesterase 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CMA1
|
chymase 1, mast cell
|
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTF1
|
cardiotrophin 1
|
|
CTSS
|
cathepsin S
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1
|
|
DAO
|
D-amino-acid oxidase
|
|
DCTN1
|
dynactin 1
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DGUOK
|
deoxyguanosine kinase
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DNA2
|
DNA replication helicase/nuclease 2
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSC3
|
desmocollin 3
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2
|
|
EFNA3
|
ephrin-A3
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELN
|
elastin
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV6
|
ets variant 6
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP6
|
fatty acid binding protein 6, ileal
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FPR3
|
formyl peptide receptor 3
|
|
FRZB
|
frizzled-related protein
|
|
FXN
|
frataxin
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GAK
|
cyclin G associated kinase
|
|
GBA
|
glucosidase, beta, acid
|
|
GDF6
|
growth differentiation factor 6
|
|
GDF7
|
growth differentiation factor 7
|
|
GDF9
|
growth differentiation factor 9
|
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRK1
|
G protein-coupled receptor kinase 1
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDC
|
histidine decarboxylase
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPLL
|
heterogeneous nuclear ribonucleoprotein L-like
|
|
HOXB13
|
homeobox B13
|
|
HOXB7
|
homeobox B7
|
|
HP
|
haptoglobin
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPG2
|
heparan sulfate proteoglycan 2
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFITM5
|
interferon induced transmembrane protein 5
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL12A
|
interleukin 12A
|
|
IL13
|
interleukin 13
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
INS
|
insulin
|
|
INSIG1
|
insulin induced gene 1
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNV2
|
potassium channel, voltage gated modifier subfamily V, member 2
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KL
|
klotho
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
LALBA
|
lactalbumin, alpha-
|
|
LARP4
|
La ribonucleoprotein domain family, member 4
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LCN2
|
lipocalin 2
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LMAN1
|
lectin, mannose-binding, 1
|
|
LMNA
|
lamin A/C
|
|
LOX
|
lysyl oxidase
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MALT1
|
MALT1 paracaspase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARK4
|
MAP/microtubule affinity-regulating kinase 4
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEFV
|
Mediterranean fever
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR106B
|
microRNA 106b
|
|
MIR145
|
microRNA 145
|
|
MIR155
|
microRNA 155
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR96
|
microRNA 96
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH3
|
mutS homolog 3
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT1A
|
metallothionein 1A
|
|
MT2A
|
metallothionein 2A
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MVK
|
mevalonate kinase
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
N6AMT1
|
N-6 adenine-specific DNA methyltransferase 1 (putative)
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPY
|
neuropeptide Y
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRXN1
|
neurexin 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
PAH
|
phenylalanine hydroxylase
|
|
PANK2
|
pantothenate kinase 2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14
|
|
PAX2
|
paired box 2
|
|
PAX6
|
paired box 6
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PBX2
|
pre-B-cell leukemia homeobox 2
|
|
PCGEM1
|
PCGEM1, prostate-specific transcript (non-protein coding)
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLTP
|
phospholipid transfer protein
|
|
PMPCB
|
peptidase (mitochondrial processing) beta
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRLR
|
prolactin receptor
|
|
PROM1
|
prominin 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRTN3
|
proteinase 3
|
|
PSAP
|
prosaposin
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMD2
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTX3
|
pentraxin 3, long
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
RAD51
|
RAD51 recombinase
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBSN
|
rabenosyn, RAB effector
|
|
RET
|
ret proto-oncogene
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNH1
|
ribonuclease/angiogenin inhibitor 1
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPSA
|
ribosomal protein SA
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SDCCAG8
|
serologically defined colon cancer antigen 8
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERBP1
|
SERPINE1 mRNA binding protein 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFN
|
stratifin
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIRT1
|
sirtuin 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A4
|
solute carrier family 12 (potassium/chloride transporter), member 4
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2
|
|
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SNAPC1
|
small nuclear RNA activating complex, polypeptide 1, 43kDa
|
|
SNAPC4
|
small nuclear RNA activating complex, polypeptide 4, 190kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SP1
|
Sp1 transcription factor
|
|
SPAST
|
spastin
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
SSRP1
|
structure specific recognition protein 1
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STX11
|
syntaxin 11
|
|
STX16
|
syntaxin 16
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TCF21
|
transcription factor 21
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERC
|
telomerase RNA component
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TFF3
|
trefoil factor 3 (intestinal)
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TH
|
tyrosine hydroxylase
|
|
TIMELESS
|
timeless circadian clock
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRD
|
T cell receptor delta locus
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRG
|
T cell receptor gamma locus
|
|
TRIM5
|
tripartite motif containing 5
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTR
|
transthyretin
|
|
UBQLN1
|
ubiquilin 1
|
|
UBQLN2
|
ubiquilin 2
|
|
UCN2
|
urocortin 2
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
UROD
|
uroporphyrinogen decarboxylase
|
|
USP6
|
ubiquitin specific peptidase 6
|
|
VAMP4
|
vesicle-associated membrane protein 4
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNK3
|
WNK lysine deficient protein kinase 3
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
